NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

Euclidean Capital LLC's Holding History (CIK: 0001825034)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 992,168 Value ($000) $1,578 Avg Close — Range —
Q4 2023
Shares 992,168 Value ($000) $852 Avg Close — Range —
Q3 2023
Shares 992,168 Value ($000) $1,062 Avg Close — Range —
Q2 2023
Shares 746,674 Value ($000) $1,934 Avg Close — Range —
Q1 2023
Shares 746,674 Value ($000) $3,046 Avg Close — Range —
Q4 2022
Shares 746,674 Value ($000) $3,748 Avg Close — Range —
Q3 2022
Shares 746,674 Value ($000) $9,766 Avg Close — Range —
Q2 2022
Shares 746,674 Value ($000) $9,572 Avg Close — Range —
Q1 2022
Shares 746,674 Value ($000) $11,387 Avg Close — Range —
Q4 2021
Shares 746,674 Value ($000) $13,224 Avg Close — Range —
Q3 2021
Shares 832,274 Value ($000) $17,494 Avg Close — Range —
Q2 2021
Shares 1,493,349 Value ($000) $29,449 Avg Close — Range —
Q1 2021
Shares 1,493,349 Value ($000) $43,412 Avg Close — Range —
Q4 2020
Shares 2,083,602 Value ($000) $63,133 Avg Close — Range —